Маркова, М. и Христов, Г. (2023) „Reporting of R&D Costs Under IAS 38 – The Case of Biopharmaceutical Companies“, Научни трудове, (4), стр. 57–65. doi:https://doi.org/10.37075/RP.2022.4.04.